Data month 2026-08
According to AlphaMoat, in 2026-08 Ataraxis AI (ataraxis.ai) received 4,564 monthly visits (-5.1% MoM) — ranked #12,555 of 17,407 AI websites with traffic data, and #2,099 of 3,173 in Industry Services; its largest market is United States (100.0% of visits).
Monthly Visits · 2026-08
4.6K-5.1%
Overall Rank (17,407)
#12,555
Industry Services Rank (3,173)
#2,099
Top Market
United States100.0%
What is Ataraxis AI
Product Overview
Ataraxis AI is an AI research company focused on precision medicine; its core product, Ataraxis Breast, uses causal representation learning to predict patients' cancer recurrence risk and chemotherapy benefit.
Key Features4 items
- 01Recurrence risk assessment
- 02Chemotherapy benefit assessment
- 03Neoadjuvant response assessment
- 04Research and ordering portals
12-Month Traffic Trend
Hover for monthly values
Latest 4.6KMoM-5.1%
2026-06
4.5K
—
2026-07
4.8K
+6.3%
2026-08
4.6K
-5.1%
Visits by Country · Top 5
2026-08 · Share of total visits
United States
4,564100.0%
Popular in Industry Services
Click for details, or "+ Compare" to compare with Ataraxis AI
Data month: 2026-08 · Visit figures are third-party traffic estimates aggregated monthly — best for scale and trends. Multiple domains of the same product are merged. See methodology.